314. Deputy Naoise Ó Cearúil asked the Minister for Health the status of the reimbursement process for givinostat for the treatment of Duchenne muscular dystrophy; the timeline for a decision following consideration by the HSE Drugs Group; the steps being taken to ensure timely access for eligible patients once a decision is made; and if she will make a statement on the matter. [44665/26]

Summary

314. Deputy Naoise Ó Cearúil asked the Minister for Health the status of the reimbursement process for givinostat for the treatment of Duchenne muscular dystrophy; the timeline for a decision following consideration by the HSE Drugs Group; the steps being taken to ensure timely access for eligible patients once a decision is made; and if she will make a statement on the matter. [44665/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 11 June 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.